Search
forResearch 10 of 1000+
- Psychiatric and sexual dysfunction warnings strengthened for finasteride and dutasteride
- Post-finasteride syndrome: pharmacists must lead the conversation on patient safety
- The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?
- Depression, suicidal thoughts with finasteride (Propecia)
- Finasteride drug safety alert
- Safety update: psychiatric and sexual adverse effects with finasteride
- This sector needs laser protection supervisors
- Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine
- Marketing Experimental Stem Cell Therapies in the UK: Biomedical Lifestyle Products and the Promise of Regenerative Medicine in the Digital Era
- Comparative Analysis of Labeling and Claim Substantiation Requirements for Herbal Hair Products across Different Regulatory Jurisdictions
Learn 1 of 28
All learn results →Community
— no results
Try a deeper search in community →